Global X SandP 500 Catholic Values ETF (CATH)
Live price chart, market sentiment, and community perspectives for Global X SandP 500 Catholic Values ETF (NASDAQ: CATH).
Live price chart, market sentiment, and community perspectives for Global X SandP 500 Catholic Values ETF (NASDAQ: CATH).
On our desk, we are monitoring CATH's recent surge in short interest, which jumped 92.1% by mid-July to 59,334 shares. Even though it represents only 0.4% of total shares, the rapid climb points to tactical hedging or rising skepticism around its large technology exposure amid broader manufacturing contraction indicators.
Watching the 50-day moving average near $89.56 and the recent price action around $90.84, CATH shows steady trading volume averaging over 43,000 shares daily. The days-to-cover ratio sits comfortably low at 1.4 days, suggesting that despite higher short activity, liquidity remains orderly for institutional execution.
When evaluating the risk profile for large-blend mandates, I note that CATH carries a beta of 1.02 and a 5-year Sharpe ratio of 0.54, tracking closely with the SandP 500 Catholic Values Index. However, its 5-year downside capture of 106 indicates that risk-adjusted metrics lag slightly behind the broader index's 0.61 Sharpe.
From a valuation and forward perspective, CATH trades at a P/E ratio of roughly 25.57x with an SEC yield of 0.80%. With the Federal Reserve holding target rates in the 4.25% to 4.50% range in early 2026, the limited income buffer leaves the fund sensitive to broader equity market corrections.
In our portfolio risk reviews, CATH's historical performance remains a double-edged sword. While its 10-year annualized NAV return of 14.45% beats the category average, the 5-year window shows above-average risk without an above-average return, alongside consistently negative alpha across tested periods.
Analyzing the portfolio's structural composition, the fund's heavy 37.4% technology weighting exposes it directly to macro tech trends. Combined with early 2026 ISM PMI reports showing manufacturing in contraction territory, sector concentration risk remains a critical variable for tactical asset allocation.
Explore plasma cleansing, somatic organ swaps, and BCI.